Covid-19 Vaccine BD
Bangladesh’s Covid-19 vaccine storage capacity 140-150m: Health Minister
Health minister Zahid Maleque on Thursday reassured the people that there won’t be any problem in storing and distributing Covid-19 vaccines.
TIB seeks transparency in vaccine collection, distribution
Transparency International Bangladesh (TIB) has urged the government to ensure maximum transparency in the procurement, collection and distribution of Covid-19 vaccines.
‘Stage set for plundering’ over vaccine, alleges BNP
BNP on Monday alleged that an arrangement has been made for “plundering public money by government-backed businesspeople” in the name of procuring coronavirus vaccine.
Covid vaccination in Bangladesh to start in first week of Feb: DGHS
The much-sought Covid-19 vaccination in Bangladesh will start in the first week of February, said Director General of the Health Services (DGHS) Prof Abul Bashar Mohammad Khurshid Alam.
Bangladesh’s daily Covid-19 infection rate drops below 7%
Bangladesh saw a daily infection rate of 6.02% with 849 new cases reported until early Monday.
Covid-19: Bangladesh allows emergency use of Oxford-AstraZeneca vaccine
The government on Thursday approved the emergency use of the Oxford-AstraZeneca Covid-19 vaccine.
People still worry about vaccine availability: GM Quader
Jatiya Party Chairman GM Quader on Thursday alleged that people’s worries over getting a coronavirus vaccine are not diminishing for lack of the government’s effective steps.
Will do everything to ensure people’s civic, democratic rights: PM
Prime Minister Sheikh Hasina on Thursday said her government will do everything necessary to ensure the civic and democratic rights of the people.
Govt playing tricks over vaccine procurement: BNP
BNP leader Ruhul Kabir Rizvi on Thursday alleged that the government has been playing tricks to plunder public money in the name of procuring coronavirus vaccine.
Covid-19: Globe Biotech gets nod to manufacture vaccine for clinical trial
Bangladeshi pharmaceutical company Globe Biotech has gotten approval from the Directorate General of Drug Administration (DGDA) for manufacturing Covid-19 vaccine for clinical trial.